|
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37638000 | Oncogenic Ras and οNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. | Front Immunol | 2023 |
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37638000 | Oncogenic Ras and οNp63α cooperate to recruit immunosuppressive polymorphonuclear myeloid-derived suppressor cells in a mouse model of squamous cancer pathogenesis. | Front Immunol | 2023 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 36119107 | Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist. | Front Immunol | 2022 |
| 35151924 | LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis. | Acta Biomater | 2022 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 36119107 | Lipopolysaccharide sensitizes the therapeutic response of breast cancer to IAP antagonist. | Front Immunol | 2022 |
| 35151924 | LncRNA Neat1 promotes the macrophage inflammatory response and acts as a therapeutic target in titanium particle-induced osteolysis. | Acta Biomater | 2022 |
| 34167951 | The Proteomic Landscape of Growth Factor Signaling Networks Associated with <i>FAT1</i> Mutations in Head and Neck Cancers. | Cancer Res | 2021 |
| 34167951 | The Proteomic Landscape of Growth Factor Signaling Networks Associated with <i>FAT1</i> Mutations in Head and Neck Cancers. | Cancer Res | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 33036368 | Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? | Cancers (Basel) | 2020 |
| 33036368 | Regulation of NFκB Signalling by Ubiquitination: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma? | Cancers (Basel) | 2020 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |
| 30393585 | Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. | Oncoimmunology | 2018 |
| 30058293 | Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma. | J Pathol Clin Res | 2018 |
| 29921694 | Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. | Cancer Res | 2018 |
| 29959199 | Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133<sup>+</sup> Skin Cancer Stem Cells. | Mol Cancer Ther | 2018 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |
| 30288354 | WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. | Oncoimmunology | 2018 |
| 29959199 | Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133<sup>+</sup> Skin Cancer Stem Cells. | Mol Cancer Ther | 2018 |
| 30058293 | Current status of clinical testing for human papillomavirus in oropharyngeal squamous cell carcinoma. | J Pathol Clin Res | 2018 |
| 29921694 | Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. | Cancer Res | 2018 |
| 30393585 | Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancer. | Oncoimmunology | 2018 |
| 30288354 | WEE1 kinase inhibition reverses G2/M cell cycle checkpoint activation to sensitize cancer cells to immunotherapy. | Oncoimmunology | 2018 |
| 28039268 | Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways. | Clin Cancer Res | 2017 |
| 28915554 | Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells. | Oncotarget | 2017 |
| 28364000 | Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. | Cancer Res | 2017 |
| 28039268 | Therapeutic Small Molecules Target Inhibitor of Apoptosis Proteins in Cancers with Deregulation of Extrinsic and Intrinsic Cell Death Pathways. | Clin Cancer Res | 2017 |
| 28295216 | Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus. | Cancer | 2017 |
| 28364000 | Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ. | Cancer Res | 2017 |
| 28295216 | Genetic alterations in TRAF3 and CYLD that regulate nuclear factor κB and interferon signaling define head and neck cancer subsets harboring human papillomavirus. | Cancer | 2017 |
| 28915554 | Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells. | Oncotarget | 2017 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 27208423 | TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry. | Biochim Biophys Acta | 2016 |
| 27469115 | SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2. | Cancer Res | 2016 |
| 27208423 | TRAF3 signaling: Competitive binding and evolvability of adaptive viral molecular mimicry. | Biochim Biophys Acta | 2016 |
| 27469115 | SMAC Mimetic Birinapant plus Radiation Eradicates Human Head and Neck Cancers with Genomic Amplifications of Cell Death Genes FADD and BIRC2. | Cancer Res | 2016 |
| 24219320 | The PI3K/Akt/mTOR axis in head and neck cancer: functions, aberrations, cross-talk, and therapies. | Oral Dis | 2015 |
| 25798061 | MEK inhibitor PD-0325901 overcomes resistance to CK2 inhibitor CX-4945 and exhibits anti-tumor activity in head and neck cancer. | Int J Biol Sci | 2015 |